Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Open Label, Clinical Trial Comparing a QD Regimen of Didanosine, Lamivudine and Efavirenz With a Standard BID Regimen of Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of Human Immunodeficiency Virus Infection (GESIDA 39/03)
Conditions
Interventions
didanosine + lamivudine + efavirenz
Locations
57
Spain
Hospital Universitario de San Juan de Alicante
Alicante, Alicante, Spain
Hospital General de Área de Elda
Elda, Alicante, Spain
Hospital de Orihuela-Vega Baja, San Bartolomé-Orihuela
Orihuela, Alicante, Spain
Hospital Son Dureta
Palma de Mallorca, Balearic Islands, Spain
Hospital Son Llatzer
Palma de Mallorca, Balearic Islands, Spain
Hospital del Mar
Barcelona, Barcelona, Spain
Start Date
June 1, 2004
Completion Date
November 1, 2006
Last Updated
October 16, 2007
NCT04142047
NCT06694805
NCT07428330
NCT07225530
NCT06665646
NCT05897099
Lead Sponsor
Clinical Trial Agency of HIV Study Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions